[ET Net News Agency, 20 January 2020] China Resources Pharmaceutical Group Limited
(03320) said its subsidiary Dong-E-E-Jiao has announced that the net loss attributable to
the shareholders for the year ended 31 December 2019 would range from RMB333.60 million to
RMB458.60 million, as compared to the net profit of RMB2,084.8661 million for the same
period last year.
The change in results was mainly due to the impact of various factors in recent years,
such as the general macro-environment and the gradually receding market expectation for
value recovery. (RC)